Skip to main content
. Author manuscript; available in PMC: 2025 Feb 1.
Published in final edited form as: Eur Urol Oncol. 2023 Jul 11;7(1):83–90. doi: 10.1016/j.euo.2023.05.013

Table 4 –

Grade 5 adverse events

Treatment arm Patient Category Term Relationship
to treatment		 Days from
start of
treatment		 Days from
end ofM
treatment
RT + paclitaxel + trastuzumab A Gastrointestinal Colonic perforation Possibly 53 10
RT + paclitaxel B Pulmonary/upper respiratory Aspiration Unrelated 31 2
C Death Sudden death Unrelated 47 4

CTCAE = Common Terminology Criteria for Adverse Events; RT = radiotherapy.

Adverse events were graded with CTCAE version 3.0.